Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy

PURPOSE: Androgen receptor (AR) signaling is important in prostate cancer progression, and therapies that target this pathway have been the mainstay of treatment for advanced disease for over 70 years. Tumors eventually progress despite castration through a number of well-characterized mechanisms; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Cmero, Marek, Kurganovs, Natalie J., Stuchbery, Ryan, McCoy, Patrick, Grima, Corrina, Ngyuen, Anne, Chow, Ken, Mangiola, Stefano, Macintyre, Geoff, Howard, Nicholas, Kerger, Michael, Dundee, Philip, Ruljancich, Paul, Clarke, David, Grummet, Jeremy, Peters, Justin S., Costello, Anthony J., Norden, Sam, Ryan, Andrew, Parente, Phillip, Hovens, Christopher M., Corcoran, Niall M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238292/
https://www.ncbi.nlm.nih.gov/pubmed/34322653
http://dx.doi.org/10.1200/PO.20.00337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238292/
https://www.ncbi.nlm.nih.gov/pubmed/34322653
http://dx.doi.org/10.1200/PO.20.00337

Ejemplares similares